The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges
Due to the transformation of artificial intelligence (AI) tools and technologies, AI-driven drug discovery has come to the forefront. It reduces the time and expenditure. Due to these advantages, pharmaceutical industries are concentrating on AI-driven drug discovery. Several drug molecules have bee...
Saved in:
Main Authors: | Chiranjib Chakraborty (Author), Manojit Bhattacharya (Author), Sang-Soo Lee (Author), Zhi-Hong Wen (Author), Yi-Hao Lo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development
by: Chiranjib Chakraborty, et al.
Published: (2023) -
Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential
by: Ashish Ranjan Sharma, et al.
Published: (2021) -
The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC initiative
by: Chiranjib Chakraborty, et al.
Published: (2023) -
Evaluation of differentially expressed genes during replication using gene expression landscape of monkeypox-infected MK2 cells: A bioinformatics and systems biology approach to understanding the genomic pattern of viral replication
by: Chiranjib Chakraborty, et al.
Published: (2023) -
Can artificial intelligence-strengthened ChatGPT or other large language models transform nucleic acid research?
by: Srijan Chatterjee, et al.
Published: (2023)